ANGPTL8 and metabolic dysfunction-associated steatotic liver disease: Serum ANGPTL8 levels could serve as a potential and specific diagnostic marker for liver fibrosis, and targeting ANGPTL8 shows significant promise in the development of novel therapies for treating NAFLD-related liver fibrosis [15].